IsoRay ink distribution deal with GE subsidiary

TriMed Staff | | Health Imaging | Molecular Imaging
IsoRay Medical's subsidiary IsoRay has signed on with low-dose rate research and development group Oncura, a subsidiary of GE Healthcare, in the distribution of the I-125 brachytherapy seed, OncoSeed.

Richland, Wash.-based IsoRay produces Cesium-131 brachytherapy seed, which offers a shorter radiation half-life than other isotopes commonly used for brachytherapy, said the company.

Arlington Heights, Ill.-based Oncura said that the brachytherapy seed will be utilized in expanding its Cesium-131 sales.

TriMed Staff

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.